Back
ESC Premium Access

Effectiveness, safety, and composite clinical outcomes between apixaban and other oral anticoagulants for non-valvular atrial fibrillation patients in the US Medicare population

Session: Poster Session 5 - Atrial fibrillation - Stroke prevention 1
Topic: Oral Anticoagulation
Speaker: Mr A. Dhamane (Lawrenceville, US)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Mr Amol Dhamane

Bristol-Myers Squibb, Lawrenceville (United States of America)
0 follower

9 more presentations in this session

Different obesity paradox of ischemic stroke without and with atrial fibrillation

Speaker: Associate Professor Y. Baek (Incheon, KR)

Access
Abstract
Thumbnail

Anticoagulation control in octogenarian patients receiving vitamin K antagonists for stroke prevention in atrial fibrillation: the west birmingham AF project

Speaker: Doctor H. Zulkifly (Selangor, MY)

Access
Abstract
Slides
Thumbnail

Temporal trends in antithrombotic patterns for stroke prevention in patients with atrial fibrillation and wide spectrum of coronary artery disease

Speaker: Associate Professor B. Hudzik (Zabrze, PL)

Access
Abstract
Slides
Thumbnail

Dabigatran in real-world asian patients with atrial fibrillation with low body weight: nationwide cohort data covering the entire korean population

Speaker: Doctor D. Kim (Seoul, KR)

Access
Abstract
Slides
Thumbnail

Secondary stroke prophylaxis in atrial fibrillations patients with chronic kidney disease: a nationwide cohort study

Speaker: Mr M. Christensen (Copenhagen, DK)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation - Stroke prevention 1

Speakers: Mr A. Dhamane, Associate Professor Y. Baek, Doctor H. Zulkifly, Associate Professor B. Hudzik, Doctor D. Kim...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb